NIPER Mohali Placements 2025: Highest & Average Package, Top Recruiters

In 2025, NIPER Mohali students received offers across a diverse set of roles, primarily concentrated in R&D, Regulatory Affairs, Formulation Development, Analytical Sciences, Quality Assurance, and Pharma Management. R&D remained the dominant domain with 75% of total offers, particularly benefitting MPharm Pharmaceutics and MS (Pharm) Biotechnology students. Regulatory roles were driven by Zydus Cadila and Dr. Reddy’s, while Novartis hired MBA (Pharm) graduates for managerial positions. Analyst and formulation roles from Himalaya, Lupin, and Biocon added strong mid-tier opportunities. These varied profiles ensured that each specialization had industry-relevant placement outcomes across major pharma hubs.

The Placement Cell at NIPER Mohali plays a central role in guiding students through recruitment by organizing 30+ training workshops in 2024–25. These include aptitude training sessions with Zydus, soft-skill programs with Novartis, and multiple mock interviews aimed at improving confidence. The department also conducts industrial visits to companies like Dr. Reddy’s, strengthening exposure to real-world operations. Additionally, the cell facilitated 150+ internships at leading organizations such as Pfizer, which significantly boosted pre-placement offers. This sustained training ecosystem aims to push placement rates toward 90% and ensures students meet evolving industry expectations.

The 2025 placement season at NIPER Mohali was heavily dominated by R&D roles, which accounted for nearly 75% of total offers. This hiring pattern aligns with the institute's strong research orientation and industry demand for specialized skills in formulations, drug development, and biotechnology research. Regulatory affairs contributed to about 20% of placements, particularly benefiting students from MPharm Regulatory Toxicology. Remaining offers were distributed across analytical sciences, QA/QC, and pharmaceutical management. All placements were domestic, concentrated in pharma hubs such as Hyderabad and Mumbai, with companies like Dr. Reddy’s, Zydus, Syngene, and Novartis driving demand.

Placement trends at NIPER Mohali indicate steady upward progress, with PG students placed rising from 185 in 2023, to 200 in 2024, and 213 in 2025. Median salaries also improved from Rs. 5.5 Lakhs in 2023 to Rs. 6.05 Lakhs in 2025, showcasing consistent value recognition for NIPER graduates. The total number of offers climbed to over 250, supported by an expanded recruiter portfolio and a stronger emphasis on R&D roles. The three-year trend reflects a gradual strengthening of employer connections and increased hiring for formulation, analytics, biotechnology, and regulatory positions across domestic pharmaceutical hubs.

NIPER Mohali recorded 250+ job offers during the 2025 placement cycle, marking a 12% increase compared to the previous year’s tally of 223 offers. The rise reflects improving market conditions in the pharma sector and greater recruiter participation. Approximately 40 organizations participated, generating multiple offers across MPharm, MS (Pharm), MBA (Pharm), and MTech programs. The offer-to-student ratio improved due to repeat visits from companies like Dr. Reddy’s, Zydus Cadila, Syngene, and Novartis. Off-campus opportunities through alumni networks also contributed an additional 20% to the overall offer count, further enhancing placement outcomes.

The 2025 placement season witnessed participation from leading pharmaceutical and biotech organizations, with Pfizer, Dr. Reddy’s, Novartis, Zydus Cadila, Syngene, Biocon, Himalaya, and Lupin emerging as top recruiters. Pfizer offered premium R&D roles at Rs. 15 Lakhs, while Dr. Reddy’s provided the highest volume of offers—35+ positions at Rs. 5.5 Lakhs. Novartis hired extensively from MBA (Pharm) with Rs. 10 Lakhs packages. Syngene recruited 20 MS Biotechnology students at Rs. 7 Lakhs. These companies contributed to over 250 offers and strengthened NIPER Mohali’s placement profile through domain-specific roles.

Among all postgraduate programs, MPharm emerged as the strongest performer during NIPER Mohali Placements 2025, registering 120+ placements, which amounted to more than half of the total offers. MPharm Pharmaceutics and Regulatory Toxicology students benefited from robust demand in formulations, analytical sciences, and regulatory functions, with the highest package of Rs. 15 Lakhs also emerging from this stream. MS (Pharm) Biotechnology followed with 45 placements, largely driven by Syngene and Biocon’s hiring at Rs. 7–12 Lakhs. MBA (Pharm) students also secured managerial roles in Novartis, recording packages up to Rs. 10 Lakhs, highlighting balanced outcomes across branches.

For the 2025 placement cycle, NIPER Mohali recorded an average package of Rs. 6–8 Lakhs, reflecting strong hiring sentiment across pharma and biotech domains. According to official NIRF 2025 data, the median salary for two-year PG programs stood at Rs. 6.05 Lakhs, indicating consistency in offers across most branches. Nearly 70% of placements fell in the Rs. 5.5–7 Lakhs range, with mass recruiters like Dr. Reddy’s, Zydus Cadila, and Himalaya driving volume hiring. The average package was supported by solid R&D recruitment, patent-driven profiles, and technical roles in formulations, ensuring broad opportunities across streams.

The highest package at NIPER Mohali for the 2025 placement season was Rs. 15 Lakhs, offered by Pfizer to four MPharm graduates from the Regulatory Toxicology specialization. This package represents the top tier of domestic opportunities available to NIPER students, as the institute did not record any international placements for the cycle. The Rs. 15 LPA package stands out due to the specialized skill set demanded in regulatory and R&D functions. Other top recruiters such as Novartis, Biocon, and Syngene also offered competitive salaries in the Rs. 8–12 Lakhs range across MBA (Pharm), MS (Pharm), and Biotechnology roles.

NIPER Mohali’s 2025 placement cycle demonstrated strong outcomes, with 213 out of 268 postgraduate students securing positions across major pharma and biotech companies, achieving a 79% placement rate as per NIRF 2025. Over 40 recruiters visited the S.A.S. Nagar campus, generating more than 250 offers between October 2024 and July 2025. Most roles were concentrated in regulatory affairs, formulations, and R&D, reflecting industry demand. The highest package reached Rs. 15 Lakhs at Pfizer, while average CTC ranged between Rs. 6–8 Lakhs. This performance underscores NIPER Mohali’s consistent placement momentum for PG programs.